Baseline neutrophil-lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use.
暂无分享,去创建一个
J. Bono | O. Sartor | R. Ferraldeschi | J. D. de Bono | Z. Zafeiriou | J. Mateo | L. Shen | D. Bianchini | D. Lorente | A. Bahl | A. Templeton | A. Bahl | Z. Su | L. Shen